Urologen

Model: WZM0201

HK$349
Quantity : 24

Australia , Austria , Belgium , Brazil , Cambodia , Canada , China , Denmark , Finland , France , Ghana , Hong Kong , Hungary , Indonesia , Ireland , Italy , Japan , South Korea , Latvia , Luxembourg , Macau , Malaysia , Mexico , Netherlands , New Zealand , Nigeria , Norway , Pakistan , Philippines , Poland , Portugal , Russian Federation , Singapore , Slovakia , Slovenia , Spain , Sweden , Switzerland , Taiwan , Thailand , Turkey , United Arab Emirates , United Kingdom , United States , Viet Nam , Serbia

Product Description

Benign Prostatic Hyperplasia (BPH) is a disease characterized by substantial enlargement of the prostate, which .results in pressure being applied to the urethra and, ultimately, in problems related to urination.

The first clinical symptoms emerge after the age of 50 (microscopic variations in the prostate tissues may however be observed as early as after the age of 30). It applies to more than 50 % of men over the age of 50 and more than 70% of men over the age of 60. Untreated BPH results in damage to the upper urinary tract and prostate cancer is six times higher in men suffering from BPH compared to healthy men. As the illness progresses and due to age, the quality of life of the affected men tends to deteriorate, with BPH proceeding to a new stage.

Characteristics: Urologen is intended for men and represents a complex form of care for prostate.

It contains herbal extracts which have favourable effects to prostate problems or so-called manifestations of BPH of prostate. Saw Palmetto (Serenoa sp.) effect mechanism consists in positive influencing of metabolism of male sex hormones and in inhibition of creation of inflammation mediators. Urtica dioica and Arctostaphylos uva-ursi have diuretic effects, in addition, Arctostaphylos uva-ursi to disinfection of the urinary tract. Lycopene is a carotenoid gained from tomato (Lycopersicon esculentum). Epidemiological studies prove favourable effects of lycopene in reduction of a risk of prostate cancer. Active substances are solved in oil from pumpkin seeds to provide maximum bioavailability.

composition Weight/1cap.

Saw Palmetto (extract 10:1—min.30 mg; fatty acids 85-95%) 300,0 mg

Lycopene (from extract of tomato 6%) 500,0 ug

Arctostaphylos uva-ursi  (extract 4:1-12,50 mg) 50,0 mg

Urtica dioica (extract 4:1-62,50 mg) 250,0 mg

Pumpkin (seed oil) 300,0 mg

Urologen is a preparation that can be recommended preventively, as well as whenever an effective solution needs to be provided to men who already suffer from symptoms of BPH or other prostate problems.

Effects:

 it helps with prostate symptoms (urinate disorder, frequent, painful, discontinuous and strain voiding) and supports good function of reproductive organs and urinary system in the patients with Benign Prostatic Hyperplasia 

 it inhibits prostate cell proliferation thus has a positive influence on decreasing formation of a prostate cancer

Dosing: 2 softgels daily, in case of disorder up to 4 softgels daily

 

Warning: Do not exceed the stated recommended daily dose. Keep out of the reach of children. It is not suitable for children under the age of 3 or persons sensitive to bees' products. Store in a dry and dark place, under the temperature of 25 °C.

Special cautions: No special cautions.

Quality guarantee - Urologen is Made in EU product by WALMARK company in GMP certified production with strict control of input materials and of the whole production process. The batch has been measured for content of active ingredients and put to the test. Your batch number can be found printed on the Urologen box.

Urologen is a unique combination of 5 active ingredients.

Clinical evidence: Effect of each active ingredient in Prostenal has been clinically tested and positive effect of Urtica diotica and Saw Palmeto combination has been clinically approved. According to postmarketing study 95,2 % of users in Europe were satisfied with Prostenal effect.

Urologen - Intelligent comprehensive care for the prostate